AccuStem Sciences, Inc.
ACUT
$0.98
$0.09410.61%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 24.84% | 11.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.36% | 13.38% | |||
| Operating Income | -18.36% | -13.38% | |||
| Income Before Tax | -18.36% | -13.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.36% | -13.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.36% | -13.38% | |||
| EBIT | -18.36% | -13.38% | |||
| EBITDA | -18.56% | -13.41% | |||
| EPS Basic | -8.81% | -10.03% | |||
| Normalized Basic EPS | -8.54% | -9.94% | |||
| EPS Diluted | -8.81% | -10.03% | |||
| Normalized Diluted EPS | -8.54% | -9.94% | |||
| Average Basic Shares Outstanding | 8.73% | 3.13% | |||
| Average Diluted Shares Outstanding | 8.73% | 3.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||